Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Diabetes|August 12, 2011
Rituximab selectively suppresses specific islet antibodiesLiping Yu, Kevan Herold, Heidi Krause-Steinrauf, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 7, 2007
Receptor for advanced glycation end products expression on T cells contributes to antigen-specific cellular expansion in vivoBernhard Moser, Dharmesh D Desai, Matthew P Downie, et al.Journal of Leukocyte Biology|May 22, 2007
Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stressKevan Herold, Bernhard Moser, Yali Chen, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 18, 2012
Enhanced anti-serpin antibody activity inhibits autoimmune inflammation in type 1 diabetesJan Czyzyk, Octavian Henegariu, Paula Preston-Hurlburt, et al.Journal for Immunotherapy of Cancer|June 16, 2019
B cell depletion or absence does not impede anti-tumor activity of PD-1 inhibitorsWilliam Damsky, Lucia Jilaveanu, Noel Turner, et al.Endocrinology|July 3, 2004
Identification of tissue-restricted transcripts in human isletsAntonella Maffei, Zhuoru Liu, Piotr Witkowski, et al.Diabetes|August 5, 2010
Glucose excursions between states of glycemia with progression to type 1 diabetes in the diabetes prevention trial-type 1 (DPT-1)Jay M Sosenko, Jay S Skyler, Jeffrey P Krischer, et al.Annals of the New York Academy of Sciences|March 23, 2007
Development of new-generation HU-PBMC-NOD/SCID mice to study human islet alloreactivityMarie King, Todd Pearson, Leonard D Shultz, et al.Nuclear Medicine and Biology|October 19, 2006
Visualizing pancreatic beta-cell mass with [11C]DTBZNorman Ray Simpson, Fabiola Souza, Piotr Witkowski, et al.Annals of the New York Academy of Sciences|July 23, 2005
Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesisWilliam Kim, Barry I Hudson, Bernhard Moser, et al.Pageof 3